Velan Capital

Velan Capital is a private equity firm specializing in healthcare investments, particularly in the specialty pharmaceutical industry. The firm focuses on public development-stage and commercial-stage companies that are generating revenue, preparing for commercial launch, or are in late-stage development. Velan Capital seeks undervalued opportunities and engages actively with management teams and boards to support growth and build successful businesses.

Established in 2020, Velan Capital employs a high-conviction long/short public equity strategy focused exclusively on the healthcare sector, aiming to produce superior risk-adjusted returns. The firm's team comprises experienced professionals with decades of operating and investing experience in public and private companies, many of which they have started, built, and helped exit.

Velan Capital's investment approach is characterized by a concentrated portfolio, enabling better insights and support for its portfolio companies. As active investors, they assist management teams in various areas, including commercialization, product development, business development, strategy, finance, social responsibility, and corporate governance. The firm's commitment to its investments is underscored by investing its own capital alongside external investors, ensuring proper alignment between general partners and limited partners.